Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.6 - $1.0 $15 - $25
-25 Reduced 8.31%
276 $0
Q4 2022

Feb 10, 2023

BUY
$0.5 - $17.4 $12 - $434
25 Added 9.06%
301 $0
Q2 2022

Aug 12, 2022

BUY
$0.98 - $1.68 $270 - $463
276 New
276 $0
Q1 2022

May 16, 2022

SELL
$1.19 - $1.71 $51 - $73
-43 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$1.58 - $2.77 $28 - $49
-18 Reduced 29.51%
43 $0
Q3 2021

Nov 15, 2021

SELL
$2.78 - $3.63 $14,278 - $18,643
-5,136 Reduced 98.83%
61 $0
Q2 2021

Sep 13, 2021

BUY
$1.8 - $5.25 $9,354 - $27,284
5,197 New
5,197 $19,000

Others Institutions Holding PRPO

# of Institutions
1
Shares Held
340
Call Options Held
0
Put Options Held
0

About Precipio, Inc.


  • Ticker PRPO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 22,736,500
  • Market Cap $143M
  • Description
  • Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...
More about PRPO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.